IGF-1 LR3 — Growth-Factor & Cellular Signaling Research
A modified insulin-like growth factor analog studied around the biology of cellular growth signaling, metabolism, protein synthesis, and tissue adaptation, with particular interest in the molecular pathways regulated by the IGF-1 receptor.
IGF-1 LR3 (Long R3 IGF-1) is a synthetic analog of insulin-like growth factor-1 engineered with structural modifications that alter its interactions with IGF-binding proteins and extend its biological activity compared with native IGF-1 in experimental systems. Research involving IGF-1 biology explores IGF-1 receptor signaling, PI3K/AKT and MAPK pathways, cellular proliferation and differentiation, glucose and amino-acid metabolism, and skeletal-muscle biology. Evidence involving IGF-1 LR3 itself is substantially more limited than research on endogenous IGF-1, and IGF-1 LR3 is not an FDA-approved medication.
Research Focus: IGF-1 Receptor Signaling • PI3K/AKT Pathways • Cellular Growth & Differentiation • Protein Metabolism • Skeletal-Muscle Biology • Metabolic Signaling • Tissue Adaptation
A modified growth-factor research peptide for those interested in the science of IGF-1 signaling, cellular growth and adaptation, metabolic communication, and the molecular pathways involved in tissue biology.
Educational Disclaimer
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.
IGF-1 LR3 — Growth-Factor & Cellular Signaling Research
A modified insulin-like growth factor analog studied around the biology of cellular growth signaling, metabolism, protein synthesis, and tissue adaptation, with particular interest in the molecular pathways regulated by the IGF-1 receptor.
IGF-1 LR3 (Long R3 IGF-1) is a synthetic analog of insulin-like growth factor-1 engineered with structural modifications that alter its interactions with IGF-binding proteins and extend its biological activity compared with native IGF-1 in experimental systems. Research involving IGF-1 biology explores IGF-1 receptor signaling, PI3K/AKT and MAPK pathways, cellular proliferation and differentiation, glucose and amino-acid metabolism, and skeletal-muscle biology. Evidence involving IGF-1 LR3 itself is substantially more limited than research on endogenous IGF-1, and IGF-1 LR3 is not an FDA-approved medication.
Research Focus: IGF-1 Receptor Signaling • PI3K/AKT Pathways • Cellular Growth & Differentiation • Protein Metabolism • Skeletal-Muscle Biology • Metabolic Signaling • Tissue Adaptation
A modified growth-factor research peptide for those interested in the science of IGF-1 signaling, cellular growth and adaptation, metabolic communication, and the molecular pathways involved in tissue biology.
Educational Disclaimer
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.